Malaysian Genomics Resource (0155) — Cash Flow-to-Debt Ratio
Malaysian Genomics Resource (0155) has a Cash Flow-to-Debt Ratio of 0.03x as of March 2026, meaning its operating cash flow of RM98.00K could theoretically repay 0% of its total liabilities (RM3.12 Million) in one year. Check Malaysian Genomics Resource investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Malaysian Genomics Resource Cash Flow-to-Debt Ratio (2015–2026)
Historical debt coverage capacity for Malaysian Genomics Resource across 12 annual periods. Also explore balance sheet size of Malaysian Genomics Resource for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Malaysian Genomics Resource (2015–2026)
Year-by-year debt coverage analysis for Malaysian Genomics Resource. For market capitalisation and broader financial context, see Malaysian Genomics Resource (0155) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (MYR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.28x | RM1.10 Million | RM3.92 Million | ▲ +258.7% |
| 2025 | -0.18x | RM-744.97K | RM4.20 Million | ▲ +97.6% |
| 2024 | -7.44x | RM-24.97 Million | RM3.36 Million | ▼ -37.7% |
| 2023 | -5.40x | RM-22.07 Million | RM4.08 Million | ▼ -46069.1% |
| 2022 | 0.01x | RM56.92K | RM4.84 Million | ▲ +102.2% |
| 2021 | -0.54x | RM-2.64 Million | RM4.85 Million | ▼ -103.9% |
| 2020 | 14.09x | RM11.67 Million | RM827.98K | ▲ +43287.4% |
| 2019 | -0.03x | RM-687.64K | RM21.07 Million | ▲ +89.2% |
| 2018 | -0.30x | RM-6.34 Million | RM21.07 Million | ▼ -210.5% |
| 2017 | 0.27x | RM3.67 Million | RM13.49 Million | ▼ -84.7% |
| 2016 | 1.77x | RM3.68 Million | RM2.08 Million | ▲ +1722.3% |
| 2015 | 0.10x | RM395.83K | RM4.07 Million | — |